SPOTLIGHT -
This roundtable series discusses immunotherapy treatment used in metastatic or unresectablemelanoma, as discussed by key opinion leaders and participants at virtual live events.
The Significance of Nivolumab Plus Relatlimab for Advanced Melanoma
Jason Luke, MD, discussed the role played by the combination of nivolumab plus relatlimab in patients with advanced melanoma.